Relistor - 0008-1218-01 - (Methylnaltrexone bromide)

Alphabetical Index


Drug Information of Relistor

Product NDC: 0008-1218
Proprietary Name: Relistor
Non Proprietary Name: Methylnaltrexone bromide
Active Ingredient(s): 12    mg/.6mL & nbsp;   Methylnaltrexone bromide
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Relistor

Product NDC: 0008-1218
Labeler Name: Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021964
Marketing Category: NDA
Start Marketing Date: 20080801

Package Information of Relistor

Package NDC: 0008-1218-01
Package Description: 1 VIAL in 1 CARTON (0008-1218-01) > .6 mL in 1 VIAL

NDC Information of Relistor

NDC Code 0008-1218-01
Proprietary Name Relistor
Package Description 1 VIAL in 1 CARTON (0008-1218-01) > .6 mL in 1 VIAL
Product NDC 0008-1218
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Methylnaltrexone bromide
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20080801
Marketing Category Name NDA
Labeler Name Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc.
Substance Name METHYLNALTREXONE BROMIDE
Strength Number 12
Strength Unit mg/.6mL
Pharmaceutical Classes Opioid Antagonist [EPC],Opioid Antagonists [MoA],Quaternary Ammonium Compounds [Chemical/Ingredient]

Complete Information of Relistor


General Information